The Sputnik vaccine figures only the second to be published from a late stage human trial, coming hot on the heels of American pharmaceutical giant Pfizer earlier this week on its own promising figure of 90% effectiveness.

斯普特尼克疫苗的數據只是第二個從後期人體試驗中公佈的數據，緊隨美國製藥巨頭輝瑞公司本週早些時候對自己90%有效性的承諾數據。

The Sputnik research comes from the 1st 16,000 trial participants to receive both shots of the two dose vaccine.

斯普特尼克的研究來自第1.6萬名試驗參與者接受兩劑疫苗的注射。

Analysis was conducted after 20 participants in the trial developed covert 19 and then examined how many had received the vaccine vs placebo.

在20名試驗參與者制定了隱蔽的19後進行分析，然後檢查有多少人接受了疫苗與安慰劑。

However, outside experts said knowledge about the trials, design and protocol was sparse, making it difficult to interpret the figures.

然而，外部專家表示，對試驗、設計和方案的瞭解很少，是以很難解釋這些數字。

Yeah, the Russian direct investment fund of the main backers off the Sputnik vaccine.

是啊，俄羅斯直接投資基金的主要支持者 拒絕了斯普特尼克疫苗。

They remained positive and say it was the sort of news developers would talk about one day with their grandchildren.

他們依然很積極，說這是開發商有一天會和孫子談論的新聞。

The Russian trial announced it will continue for six more months, and data from the study will also be published in a leading international medical journal following a peer review.

俄羅斯的試驗宣佈將繼續進行6個月，研究數據也將在同行評審後在國際權威醫學雜誌上發表。